Commercial AI for CT lung cancer screening: product capabilities, coverage of nodule management tasks and supporting evidence - Quiz - MDSpire

Commercial AI for CT lung cancer screening: product capabilities, coverage of nodule management tasks and supporting evidence

  • By

  • Noa Antonissen

  • Steven Schalekamp

  • Horst K. Hahn

  • Kicky G. van Leeuwen

  • Colin Jacobs

  • May 7, 2026

  • 0 min

Share

Original Source(s)

Commercial AI for CT lung cancer screening: product capabilities, coverage of nodule management tasks and supporting evidence

  • by Noa Antonissen, Steven Schalekamp, Horst K. Hahn, Kicky G. van Leeuwen, Colin Jacobs

  • May 7, 2026

Related Content

FOXA2 in cancer: from fundamental biology to clinical translation

Research progress in imaging detection of brain metastases

Successful management of severe Pneumocystis jirovecii pneumonia with inhaled nitric oxide and individualized ventilatory strategies in an immunosuppressed patient: a case report